Tag: Sickle Cell


News

Clinical Trial Led by UTHSC’s Kenneth Ataga, MD, Results in FDA Approval of New Sickle Cell Treatment

|

Patients with sickle cell disease will soon have a new treatment option to reduce pain crises caused by obstructed blood flow. The FDA has approved use of the drug crizanlizumab based on the results of a clinical trial led by Kenneth Ataga, MD, Plough Foundation Endowed Chair in Sickle Cell Disease and director of the… Read More


News

Kenneth Ataga, MD, Co-Authors Paper on Potential New Treatment for Sickle Cell Disease

|

Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cell disease, reduced anemia and boosted… Read More


News

The VCR Distinguished Lecture Series Begins Today, Bringing Outstanding Researchers to Campus to Speak

|

In his inaugural Research Town Hall in January, Steven R. Goodman, PhD, vice chancellor for Research at the University of Tennessee Health Science Center, announced several new initiatives. One of them, the VCR Distinguished Lecture Series, designed to bring outstanding researchers to campus for talks, kicks off today at 1 p.m. with Betty Pace, MD,… Read More


News

Steven R. Goodman, PhD, Appointed Vice Chancellor for Research at UTHSC

|

Steve J. Schwab, MD, chancellor at the University of Tennessee Health Science Center (UTHSC), has named Steven R. Goodman, PhD, vice chancellor for Research. Dr. Goodman arrives at UTHSC from the SUNY (State University of New York) Upstate Medical University where he was the former vice president for Research, dean of the College of Graduate… Read More